Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Burns. 2021 Aug 18;48(7):1561–1573. doi: 10.1016/j.burns.2021.08.009

Table 3 –

Drug class by decade and diagnosis.

Decade: 2003–2009 SJS (n = 5) TENS (n = 29) SJS-TEN Overlap Syndrome (n = 11) Total (N = 45)
Allopurinol  1 (20%)    1 (3.5%)        0    2 (4.4%)
Anticonvulsant  1 (20%)    8 (28%)        4 (36%)    13 (29%)
Beta-lactam  0    5 (17%)        1 (9.1%)    6 (13%)
Fluoroquinolone  1 (20%)    2 (6.9%)        0    3 (13%)
Immunosuppressant  0    0        0    0
NSAID  0    3 (10%)        2 (18%)    5 (11%)
Other  0    2 (6.9%)        1 (9.1%)    3 (6.7%)
Other antibiotics  1 (20%)    3 (10%)        1 (9.1%)    5 (11%)
TMP-SMX  1 (20%)    5 (17%)        2 (18%)    8 (18%)

Decade: 2010–2019 SJS (n = 39) TENS (n = 34) SJS-TEN Overlap Syndrome (n = 13) Total (N = 86)

Allopurinol  4 (10%)    4 (12%)        1 (7.7%)    9 (10%)
Anticonvulsant  13 (33%)    10 (29%)        3 (23%)    26 (30%)
Beta-lactam  1 (2.6%)    5 (15%)        3 (23%)    9 (10%)
Fluoroquinolone  6 (15%)    0        1 (7.7%)    7 (8.1%)
Immunosuppressant  0    2 (5.9%)        0    2 (2.3%)
NSAID  1 (2.6%)    4 (12%)        1 (7.7%)    6 (7.0%)
Other  5 (13%)    0        0    5 (5.8%)
Other antibiotics  3 (7.7%)    1 (2.9%)        1 (7.7%)    5 (5.8%)
TMP-SMX  6 (15%)    8 (24%)        3 (23%)    17 (20%)

Overall SJS (n = 44) TENS (n = 63) SJS-TEN Overlap Syndrome (n = 24) Total (N = 131)

Allopurinol  5 (11%)    5 (7.9%)        1 (4.2%)    11 (8.4%)
Anticonvulsant  14 (32%)    18 (29%)        7 (29%)    39 (30%)
Beta-lactam  1 (2.3%)    10 (16%)        4 (17%)    15 (11%)
Fluoroquinolone  7 (16%)    2 (3.2%)        1 (4.2%)    10 (7.7%)
Immunosuppressant  0    2 (3.2%)        0    2 (1.5%)
NSAID  1 (2.3%)    7 (11%)        3 (13%)    11 (8.4%)
Other  5 (11%)    2 (3.2%)        1 (4.2%)    8 (6.1%)
Other antibiotics  4 (9.1%)    4 (6.4%)        2 (8.3%)    10 (7.6%)
TMP-SMX  7 (16%)    13 (21%)        5 (21%)    25 (19%)

Anticonvulsants: lamotrigine, phenytoin, carbamazepine, valproic acid, levitiracem, gabapentin; TMP-SMX: Trimethoprim-Sulfamethoxazole; Beta-lactams: ceftriaxone, ampicillin, piperacillin-tazobactam, penicillin G, amoxicillin, amoxicillin-clavulanate, imipenem; NSAIDs: ibuprofen, naproxen; Fluoroquinolones: ciprofloxacin, oxacillin, levofloxacin, moxifloxacin; other antibiotics: azithromycin, erythromycin, vancomycin, minocycline, rifampin, clindamycin; Other: acetaminophen, propylthiouracil, oseltamivir, loratadine, butalbital, amlodipine, possible mycoplasma infection; Immunosuppressants: rituximab, methotrexate.